Cancer Stem Cell Biomarkers: Critical Roles, Challenges, Clinical Application, and Perspectives in Cancer Therapy

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Bahrami Salehloo Elham; Mozdoori Najme; Dehghan Esmatabadi Mohammad Javad; HAJIGHOLAMI SAMIRA; BOZORGMEHR ALI

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Basic & Clinical Cancer Research Year:2021 | Volume:13 | Issue:3 Page(s): 156-174

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Cancer Stem Cell Biomarkers: Critical Roles, Challenges, Clinical Application, and Perspectives in Cancer Therapy

Author(s)

Keywords

Cancer Stem Cells (CSCs)

Cancer Therapy

Prognostic Markers

Abstract

Progress in cancer stem cells (CSCs) has opened up a new window to develop better cancer treatment methods. Several preclinical and clinical trial studies use CSCs targeting via surface markers method and inhibiting stem cell pathway to eradicate cancer. Investigations disclose that CSCs are more resistant to chemo-and radiotherapy than non-CSCs. If CSCs are destroyed with treatment, cancer cells will be deleted. This feature is mainly related to their surface biomarkers and thus, detection and Isolation of CSCs are so critical. This study introduced the most important cell surface markers of CSCs such as CD133, CD44, CD24, and CD90 and evaluated these biomarkers. Today, more than 60 ongoing trials have been evaluated, few of which are used in clinical trials to determine if a new drug is effective. Then, we discuss the challenges of several therapies.

Cites

No record.

References

Cite

APA: Copy

Bahrami Salehloo, Elham, Mozdoori, Najme, Dehghan Esmatabadi, Mohammad Javad, HAJIGHOLAMI, SAMIRA, & BOZORGMEHR, ALI. (2021). Cancer Stem Cell Biomarkers: Critical Roles, Challenges, Clinical Application, and Perspectives in Cancer Therapy. BASIC & CLINICAL CANCER RESEARCH, 13(3), 156-174. SID. https://sid.ir/paper/1004022/en

Vancouver: Copy

Bahrami Salehloo Elham, Mozdoori Najme, Dehghan Esmatabadi Mohammad Javad, HAJIGHOLAMI SAMIRA, BOZORGMEHR ALI. Cancer Stem Cell Biomarkers: Critical Roles, Challenges, Clinical Application, and Perspectives in Cancer Therapy. BASIC & CLINICAL CANCER RESEARCH[Internet]. 2021;13(3):156-174. Available from: https://sid.ir/paper/1004022/en

IEEE: Copy

Elham Bahrami Salehloo, Najme Mozdoori, Mohammad Javad Dehghan Esmatabadi, SAMIRA HAJIGHOLAMI, and ALI BOZORGMEHR, “Cancer Stem Cell Biomarkers: Critical Roles, Challenges, Clinical Application, and Perspectives in Cancer Therapy,” BASIC & CLINICAL CANCER RESEARCH, vol. 13, no. 3, pp. 156–174, 2021, [Online]. Available: https://sid.ir/paper/1004022/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops